NewLimit reports major reprogramming breakthroughs with 5x AI sampling efficiency

NewLimit, the anti-aging cell reprogramming company co-founded by Brian Armstrong, reported its summer progress: over 5,000 constructs tested in a quarter, 314x manufacturing scale-up, doubled rejuvenation in aged liver cells, and 5x AI sampling efficiency.

2026-10-22 ~ 2026-10-22 · 2 related posts

• NewLimit Reports Best Age-Reprogramming Payloads Yet, 5X Gains From Its Reprogramming AI — jacobkimmel · 2026-10-22
• NewLimit's age-reprogramming sprint: 5000+ payloads tested, 314X manufacturing scale-up — jacobkimmel · 2026-10-22